A detailed history of Eam Investors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 107,890 shares of CDNA stock, worth $2.47 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
107,890
Holding current value
$2.47 Million
% of portfolio
0.58%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$14.41 - $33.99 $1.55 Million - $3.67 Million
107,890 New
107,890 $3.37 Million
Q1 2021

May 11, 2021

SELL
$57.62 - $95.6 $1.74 Million - $2.89 Million
-30,186 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$41.43 - $77.09 $1.25 Million - $2.33 Million
30,186 New
30,186 $2.19 Million
Q3 2019

Nov 13, 2019

SELL
$20.03 - $40.08 $1.05 Million - $2.1 Million
-52,504 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $4,408 - $6,800
-171 Reduced 0.32%
52,504 $1.89 Million
Q1 2019

May 13, 2019

SELL
$22.09 - $39.21 $2 Million - $3.56 Million
-90,752 Reduced 63.27%
52,675 $1.66 Million
Q4 2018

Feb 13, 2019

BUY
$19.89 - $30.02 $1.18 Million - $1.78 Million
59,317 Added 70.52%
143,427 $3.61 Million
Q3 2018

Nov 08, 2018

SELL
$12.1 - $28.85 $718,631 - $1.71 Million
-59,391 Reduced 41.39%
84,110 $2.43 Million
Q2 2018

Aug 03, 2018

SELL
$7.93 - $15.79 $625,819 - $1.25 Million
-78,918 Reduced 35.48%
143,501 $1.76 Million
Q1 2018

May 14, 2018

SELL
$5.18 - $7.97 $11,416 - $17,565
-2,204 Reduced 0.98%
222,419 $1.77 Million
Q4 2017

May 21, 2018

SELL
$3.98 - $7.37 $594,106 - $1.1 Million
-149,273 Reduced 39.92%
224,623 $1.65 Million
Q4 2017

Feb 12, 2018

BUY
$3.98 - $7.37 $1.49 Million - $2.76 Million
373,896
373,896 $2.74 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.22B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.